| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2018-08-14 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 36,218,756 | 83.6% | EDGAR |
| SC 13D/A | 2018-08-01 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 36,218,756 | 83.6% | EDGAR |
| SC 13D/A | 2018-07-10 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 28,181,305 | 79.8% | EDGAR |
| SC 13D/A | 2018-06-20 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 28,181,305 | 79.8% | EDGAR |
| SC 13D/A | 2018-05-29 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 28,181,305 | 79.8% | EDGAR |
| SC 13G/A | 2018-02-05 | FRANKLIN RESOURCES INC | vTv Therapeutics Inc. | 850,100 | 8.8% | EDGAR |
| SC 13D/A | 2017-12-07 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 28,131,305 | 79.7% | EDGAR |
| SC 13D/A | 2017-08-16 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 25,619,933 | 78.1% | EDGAR |
| SC 13G/A | 2016-12-28 | PIPER JAFFRAY COMPANIES | vTv Therapeutics Inc. | 181,910 | 1.9% | EDGAR |
| SC 13D/A | 2016-04-06 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 25,474,933 | 77.6% | EDGAR |
| SC 13G | 2016-02-11 | PIPER JAFFRAY COMPANIES | vTv Therapeutics Inc. | 685,995 | 7.5% | EDGAR |
| SC 13D/A | 2015-10-05 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 24,959,898 | 76.1% | EDGAR |
| SC 13G | 2015-09-10 | FRANKLIN RESOURCES INC | vTv Therapeutics Inc. | 952,900 | 12.2% | EDGAR |
| SC 13D/A | 2015-08-28 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 25,462,480 | 77.6% | EDGAR |
| SC 13D | 2015-08-14 | MacAndrews & Forbes Inc. | vTv Therapeutics Inc. | 26,806,666 | 81.7% | EDGAR |